Abstract
The clinical course of 59 children, who underwent BMT during 1988–1998 with a matched unrelated donor (MUD), was compared with 59 case controls receiving a sibling donor marrow. Thirty-eight patients had haematological malignancies while 21 had a nonmalignant disorder. The cumulative incidence of acute GVHD grade II–IV was 28% for MUD recipients vs 11% (P = 0.014) for sibling recipients. Extensive chronic GVHD was rare in both groups. The 5-year probability of survival was 52% for MUD vs 77% for sibling recipients (P = 0.014). For children with malignancies the 4-year probability of survival was 52% for MUD vs 67% for sibling recipients with a RFS of 49% vs 62%. In the ALL patients the survival of the MUD recipients was 77% and equalled that of the sibling group. For SAA survival was 43% vs 86% (P = 0.09) and for metabolic disorders 63% vs 89% (P = 0.025). The transplant-related mortality was higher in the MUD group, while death due to relapse was equally distributed. These results of MUD BMT in children compare favourably with most previous reports, and support the use of alternative donors in cases who lack an HLA-identical siblings. Bone Marrow Transplantation (2000) 25, 1059–1065.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Thomas ED, Blume KG, Forman SJ . Hematopoietic Cell Transplantation, 2nd edition Blackwell Science: Malden, MA, USA 1998
Balduzzi A, Gooley T, Anasetti C et al. Unrelated donor marrow transplantation in children Blood 1995 86: 3247–3256
Winiarski J, Ringden O, Remberger M et al. Bone marrow transplantation in children using unrelated donors at Huddinge Hospital Acta Paediatrica 1996 85: 327–335
Davies SM, Wagner Je, Shu XO et al. Unrelated donor bone marrow transplantation for children with acute leukemia J Clin Oncol 1997 15: 557–565
Oakhill A, Pamphilon DH, Potter MN et al. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission Br J Haematol 1996 94: 574–578
Casper J, Camitta B, Truitt R et al. Unrelated marrow donor transplants for children with leukemia or myelodysplasia Blood 1995 85: 2354–2363
Sanders JE . Bone marrow transplantation for pediatric malignancies Pediatr Clin North Am 1997 44: 1005–1020
Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program New Engl J Med 1993 328: 593–602
Olerup O, Zetterquist H . HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor–recipient matching in cadaveric transplantation Tissue Antigens 1992 39: 225–235
Ringdén O, Remberger M, Runde V et al. Peripheral blood stem cell (PBSC) transplantation from unrelated donors: a comparison with marrow transplantation Blood 1999 94: 455–464
Ringdén O, Remberger M, Persson U et al. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings Bone Marrow Transplant 1995 15: 619–625
Ljungman P, Loré K, Aschan J et al. Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients Bone Marrow Transplant 1996 17: 583–587
Barrett AJ, Horowitz MM, Pollock BH et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission New Engl J Med 1994 331: 1253–1258
Schrøder H, Gustafsson G, Saarinen-Pihkala UM et al. Allogeneic bone marrow transplantation in second remission of acute lymphoblastic leukemia: a population based case–control study from the Nordic Countries Bone Marrow Transplantation 1999 23: 555–560
Stockschlader M, Hegewich-Becker S, Kruger W et al. Bone marrow transplantation for Philadelphia-chromosome positive acute lymphoblastic leukemia Bone Marrow Transplant 1995 16: 663–667
Beatty PG, Hansen JA, Longton GM et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies Transplantation 1991 51: 443–447
Hows JM, Bradley BA, Gore S et al. Prospective evaluation of unrelated donor bone marrow transplantation Bone Marrow Transplant 1993 12: 371–380
Locatelli F, Percivalle E, Comoli P et al. Human cytomegalovirus infection in pediatric patients given allogenic bone marrow transplantation: role of early antigenemia on patient's outcome Br J Haematol 1994 88: 64–71
Canpolat C, Cullbert S, Gardner M et al. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogenic bone marrow transplant recipients Bone Marrow Transplant 1996 17: 589–593
Ljungman P, Aschan J, Lewensohn-Fuchs I et al. Results of different stategies for reducing cytomegalovirus-associated mortality in allogenic stem cell transplant recipients Transplantation 1998 66: 1330–1334
Hongeng S, Krance R, Bowman L et al. Outcomes of transplantation with matched sibling and unrelated donor marrow in children with leukaemia Lancet 1997 350: 767–771
Gustafsson Å, Levitsky V, Zou J et al. Epstein–Barr virus (EBV) load in bone marrow transplant recipients at risk to develop post-transplant lymphoproliferative disease; prophylactic infusion of EBV-specific cytotoxic T-cells Blood 2000 95: 807–814
Weiden PL, Flournoy N, Thomas ED et al. Anti-leukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts New Engl J Med 1979 300: 1068–1073
Kolb H, Schattenberg A, Goldman J et al. for the European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients Blood 1995 86: 2041–2050
Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions following bone marrow transplantation in humans Blood 1989 75: 555–562
Pui CH . Childhood leukaemias New Engl J Med 1995 332: 1618–1630
Locatelli F, Pession A, Comoli P et al. Role of allogenic bone marrow transplantation from an HLA-identical sibling or a matched unrelated donor in treatment of children with juvenile chronic myeloid leukaemia Br J Haematol 1996 92: 49–54
Deeg HJ, Seidel K, Casper J et al. Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy Biol Blood Marrow Transplant 1999 5: 243–252
Acknowledgements
The project was supported by grants from The Swedish Children's Cancer Foundation, the Samariten Foundation, the Swedish Cancer Society (0070-B97–11XBC), the Swedish Medical Research Council (K98–06x-05971–18B), Ellen Bachrach Foundation and the Tobias Foundation.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gustafsson, Å., Remberger, M., Winiarski, J. et al. Unrelated bone marrow transplantation in children: outcome and a comparison with sibling donor grafting. Bone Marrow Transplant 25, 1059–1065 (2000). https://doi.org/10.1038/sj.bmt.1702400
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702400